Analysts' Actions: AAPL, T, AEO, CSCO, RVBD
NEW YORK (
) --
CHANGE IN RATINGS
Advance Auto
(AAP) - Get Report
rated new Buy at Deutsche. $80 price target. Company can gain market share in a favorable environment.
American Eagle Outfitters
(AEO) - Get Report
upgraded at Piper Jaffray from Neutral to Overweight. $19 price target. Business trends have remained strong in Q4.
American Eagle Outfitters upgraded at Jefferies to Buy from Hold. $21 price target. Normalizing cotton costs now a tailwind.
American Equity Investment
(AEL) - Get Report
is downgraded to hold at TheStreet Ratings.
Altera
(ALTR) - Get Report
upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $44 price target. Shipments should return to normal levels in the first half of 2012.
American Tower
(AMT) - Get Report
downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $62 price target. Premium valuation and 12-15% outperformance.
Ann Inc.
(ANN)
upgraded at Jefferies to Buy from Hold, Jefferies said. $32 price target. Normalized cotton costs are now a tailwind.
Atmel
(ATML)
upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $10 price target. Company is gaining market share in the core MCU business.
Becton Dickinson
(BDX) - Get Report
downgraded at Morgan Stanley from Equal-weight to Underweight, Morgan Stanley said. Valuation call, based on a $68 price target.
Brookdale Senior
(BKD) - Get Report
downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. $20 price target. Lower housing prices and tax headwinds could hurt earnings.
Cooper Industries
( CBE) downgraded at Credit Suisse to Neutral, Credit Suisse said. Valuation call, based on a $55 price target.
Chipotle
(CMG) - Get Report
upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $390 price target. Secular leaders should continue to outperform, despite valuation.
Cisco Systems
(CSCO) - Get Report
upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $21 price target. Current issues unlikely to persist in 2012.
CapitalSource
(CSE)
downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. $8 price target. Valuation call.
Community Health
(CYH) - Get Report
downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. $20 price target. Reimbursement headwinds will continue to affect the industry in 2012.
Energizer
(ENR) - Get Report
upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $91 price target. Company has good earnings visibility and should garner a higher price multiple.
Edwards Lifesciences
(EW) - Get Report
upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. $79 price target. Risk/reward now balanced.
Fusion-io
(FIO)
upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $30 price target. Recent pullback has created an attractive buying opportunity.
Group 1 Automotive
(GPI) - Get Report
downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $53 price target. Valuation call, as the stock is up 115% over the past 18 months.
Goodrich
( GR) downgraded at Jefferies to Hold from Buy, Jefferies said. $127.50 price target. Modest expected return for common stock based on acquisition by UTX.
HealthSouth
(HLS)
downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. $17 price target. High Medicare exposure will likely be an earnings headwind.
Hologic
(HOLX) - Get Report
downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $20 price target. Valuation call.
Hologic upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $25 price target. Organic growth can resume in the coming years.
Intersil
(ISIL)
downgraded at Goldman from Neutral to Sell, Goldman Sachs said. $9 price target. Company faces structural challenges to growth.
Microchip
(MCHP) - Get Report
downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Valuation call, as the company should not trade at a premium to its peers. $30 price target.
Paccar
(PCAR) - Get Report
downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $41 price target. Freight fundamentals are weakening in Europe.
Plantronics
(PLT) - Get Report
downgraded at Morgan Keegan from Outperform to Market Perform, Morgan Keegan said. $36 price target. Valuation call.
PMC-Sierra
(PMCS)
downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $6 price target. Company is facing delays in new product ramps.
Riverbed Technology
(RVBD)
upgraded at Oppenheimer from Perform to Outperform, Oppenheimer said. $30 price target. Checks suggest that sales are tracking at or above expectations.
Spectra Energy
(SE) - Get Report
downgraded at UBS from Buy to Neutral, UBS said. $31 price target. Valuation call.
Semtech
(SMTC) - Get Report
upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $30 price target. Company has strong financial discipline and is leveraged to positive product cycles.
Sandisk
(SNDK)
downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $51 price target. NAND flash market will likely have too much supply in the first quarter.
Spirit AeroSystems
(SPR) - Get Report
added to Priority Stock List. Expect the OEM to grow faster than the commercial aerospace market in 2012.
TripAdvisor
(TRIP) - Get Report
upgraded at BofA Merrill from Underperform to Buy, Bank of America Merril Lynch said. $32 price target. High growth and high margin characteristics coupled with recent pullback create buying opportunity.
Under Armour
(UA) - Get Report
upgraded at Baird from Neutral to Outperform, Robert Baird said. $90 price target. Company has a solid product pipeline.
Varian Medical
(VAR) - Get Report
upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $75 price target. Upside from Siemens exit offsets capex downside risk.
VF Corp
(VFC) - Get Report
upgraded at Citigroup from Neutral to Buy and added to Top Picks Live, Citigroup said. $157 price target. Strong topline growth, margin expansion, and attractive valuation.
Williams Companies
(WMB) - Get Report
downgraded at UBS from Buy to Neutral, UBS said. $28 price target. E&P spin has showcased the value of WMB's independent business.
Wolverine World Wide
(WWW) - Get Report
downgraded at Baird from Outperform to Neutral, Robert Baird said. $38 price target. Unfavorable weather could hurt reorders.
Zynga
(ZNGA) - Get Report
rated new Market Perform at BMO. $10 price target. Current valuation reflects growth potential.
STOCK COMMENTS / EPS CHANGES
Apple
(AAPL) - Get Report
estimates, target cut at Morgan Keegan.Shares of AAPL now seen reaching $513, according to Morgan Keegan. Esitmates also reduced, given lower expected iPad and Mac sales. Outperform rating.
Chesapeake Midstream
( CHKM) numbers raised at UBS. Shares of CHKM now seen reaching $32, according to UBS. Estimates also increased as $865MM dropdown from Chesapeake adds new growth platform.
Domino's Pizza
(DPZ) - Get Report
numbers boosted at Argus. Shares of DPZ now seen reaching $39, according to Argus Research. Estimates also upped, given lower expected operating expenses.
F5 Networks
(FFIV) - Get Report
estimates lowered at Oppenheimer through 2012, Oppenheimer said. Checks point to a mixed March. Outperform rating.
FMC
(FMC) - Get Report
estimates, target raised at Keybanc. Shares of FMC now seen reaching $109. Estimates also increased, given the company's strong earnings momentum. Buy rating.
Medtronic
(MDT) - Get Report
target increased at Citigroup. MDT price target increased to $44, according to Citigroup. Weakest markets are healing, and organic growth looks to accelerate. Buy rating.
St. Jude Medical
(STJ)
cut from Top Picks List at Kaufman. $42 price target. Riata and Quadra could fall short of near-term expectations.
AT&T
(T) - Get Report
estimates reduced at Goldman through 2013, Goldman Sachs said. Company is selling more smartphones. Neutral rating and $32 price target.
Varian Medical Systems
(VAR) - Get Report
numbers raised at Citigroup. Shares of VAR now seen reaching $71, according to Citigroup. Estimates also increased on radiation oncology survey results. Neutral rating.
Verizon
(VZ) - Get Report
estimates lowered at Goldman through 2013, Goldman Sachs said. Company is spending more on handset subsidies. Buy rating and $45 price target.
>To submit a news tip, email:
.
RELATED STORIES:
>>5 Worst Stocks of 2011 -- Which Are 'Buys' for 2012?
>>8 Stocks With Biggest Upside in Market Rebound
Follow
TheStreet
on
and become a fan on
This article was written by a staff member of RealMoney.com.
